REVIVE

François Franceschi2020-02-11T10:26:56+00:00

Profile

Full Name François Franceschi

Display Name François Franceschi

Forum Role: Expert

Topics Started: 0

Replies Created: 7

Affiliation:

Expertises:

Medicare’s New Technology Add-on Payment... " There are two problems with NTAP that discourage hospitals in the US from availing themselves of this money. NTAP only provides for 50% of the hospital ... " David Shlaes
1 year ago
Setting Up A 'Support' Service... " Hi everyone, Just wanted to say that I'll be attending the ASM/ESCMID meeting in Lisbon next week, and I'd be very keen to discuss any of the points raised ... " edsiegwart
1 year ago
Superiority vs. non-inferiority studies –... " The ability to recruit patients is a complex topic and influenced by many factors, mostly epidemiology of infection caused by resistant pathogens but also ... " Ursula Theuretzbacher
2 years ago
Time above MIC for AUC/MIC... " As pointed above, the main problem here is that the therapeutic window does not allow for much higher doses. " François Franceschi
2 years ago

Medicare’s New Technology Add-on Payment... " In our webinar titled “Antibacterial drugs: Clinical development for non-developers Part 1: Traditional development – tiers A and B” with David ... " Community manager
1 year ago
Setting Up A 'Support' Service... " I'm working for a CRO that is ending its microbiology drug development service. I'm looking into forming a spin out anti-infective CRO, but am keen on ... " edsiegwart
2 years ago
Superiority vs. non-inferiority studies –... " In our recent webinar titled “PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?” with William Hope, we ... " Community manager
2 years ago
Time above MIC for AUC/MIC... " In our recent webinar titled “PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?” with William Hope, we ... " Community manager
2 years ago